Yang et al. BMC Cancer 2010, 10:133 http://www.biomedcentral.com/1471-2407/10/133 novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells. Cancer Res 2006, 66:6225-6232. 19. Qin ZK, Yang JA, Ye YL, Zhang X, Xu LH, Zhou FJ, Han H, Liu ZW, Song LB, Zeng MS: Expression of Bmi-1 is a prognostic marker in bladder cancer. BMC Cancer 2009, 9:61. 20. Huang KH, Liu JH, Li XX, Song LB, Zeng MS: Association of Bmi-1 mRNA expression with differentiation, metastasis and prognosis of gastric carcinoma. Nan Fang Yi Ke Da Xue Bao 2007, 27:973-975. 21. Xie D, Sham JST, Zeng WF, Lin HL, Che LH, Wu HX, Wen JM, Fang Y, Hu L, Guan XY: Heterogeneous expression and association of b-catenin, p16 and c-myc in multistage colorectal tumorigenesis and progression detected by tissue microarray. Int J Cancer 2003, 107:896-902. 22. Xie D, Zeng YX, Wang HJ, Wen JM, Tao Y, Sham JS, Guan XY: Expression of cytoplasmic and nuclear Survivin in primary and secondary human glioblastoma. Br J Cancer 2006, 94:108-14. 23. Luo JH, Xie D, Liu MZ, Chen W, Liu YD, Wu GQ, Kung HF, Zeng YX, Guan XY: Protein expression and amplification of AIB1 in human urothelial carcinoma of the bladder and overexpression of AIB1 is a new independent prognostic marker of patient survival. Int J Cancer 2008, 122:2554-61. 24. Lynch HT, Casey MJ, Lynch J, White TE, Godwin AK: Genetics and ovarian carcinoma. Semin Oncol 1998, 25:265-80. 25. Lessard J, Schumacher A, Thorsteinsdottir U, van Lohuizen M, Magnuson T, Sauvageau G: Functional antagonism of the Polycomb-Group genes eed and BMI1 in hemopoietic cell proliferation. Genes Dev 1999, 13:2691-2703. 26. Leung C, Lingbeek M, Shakhova O, Liu J, Tanger E, Saremaslani P, Van Lohuizen M, Marino S: BMI1 is essential for cerebellar development and is overexpressed in human medulloblastomas. Nature 2004, 428:337-341. 27. Bea S, Tort F, Pinyol M, Puig X, Hernández L, Hernández S, Fernandez PL, van Lohuizen M, Colomer D, Campo E: BMI-1 gene amplification and overexpression in hematological malignancies occur mainly in mantle cell lymphomas. Cancer Res 2001, 61:2409-2412. 28. Breuer RH, Snijders P, Sutedja GT, Sewalt RG, Otte AP, Postmus PE, Meijer CJ, Raaphorst FM, Smit EF: Expression of the p16(INK4a) gene product, methylation of the p16(INK4a) promoter region and expression of the polycomb-group gene BMI-1 in squamous cell lung carcinoma and premalignant endobronchial lesions. Lung Cancer 2005, 48:299-306. 29. Van Leenders GJ, Dukers D, Hessels D, van-den-Kieboom SW, Hulsbergen CA, Witjes JA, Otte AP, Meijer CJ, Raaphorst FM: Polycombgroup oncogenes EZH2, BMI1, and RING1 are overexpressed in prostate cancer with adverse pathologic and clinical features. Eur Urol 2007, 52:455-63. 30. Stark GR, Debatisse M, Giulotto E, Wahl GM: Recent progress Iunderstanding mechanisms of mammalian DNA amplification. Cell 1989, 57:901-8. Pre-publication history The pre-publication history for this paper can be accessed here: http://www.biomedcentral.com/1471-2407/10/133/prepub doi:10.1186/1471-2407-10-133 Cite this article as: Yang et al.: Intensive expression of Bmi-1 is a new independent predictor of poor outcome in patients with ovarian carcinoma. BMC Cancer 2010 10:133. Page 9 of 9 Submit your next manuscript to BioMed Central and take full advantage of: • Convenient online submission • Thorough peer review • No space constraints or color ﬁgure charges • Immediate publication on acceptance • Inclusion in PubMed, CAS, Scopus and Google Scholar • Research which is freely available for redistribution Submit your manuscript at www.biomedcentral.com/submit